The role of IL-10 in promoting disease progression in leishmaniasis

被引:390
|
作者
Kane, MM [1 ]
Mosser, DM [1 ]
机构
[1] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 166卷 / 02期
关键词
D O I
10.4049/jimmunol.166.2.1141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the role of IL-10 in cutaneous leishmaniasis, we examined lesion development following Leishmania major infection of genetically susceptible BALB/c mice lacking IL-10. Whereas normal BALB/c mice developed progressive nonhealing lesions with numerous parasites within them, IL-10(-/-) BALB/c mice controlled disease progression, and had relatively small lesions with 1000-fold fewer parasites within them by the fifth week of infection. We also examined a mechanism whereby Leishmania induced the production of IL-10 from macrophages. We show that surface IgG on Leishmania amastigotes allows them to ligate Fc gamma receptors on inflammatory macrophages to preferentially induce the production of high amounts of IL-10, The IL-10 produced by infected macrophages prevented macrophage activation and diminished their production of IL-12 and TNF-alpha. In vitro survival assays confirmed the importance of IL-10 in preventing parasite killing by activated macrophages. Pretreatment of monolayers with either rIL-10 or supernatants from amastigote-infected macrophages resulted in a dramatic enhancement in parasite intracellular survival. These studies indicate that amastigotes of Leishmania use an unusual and unexpected virulence factor, host IgG. This IgG allows amastigotes to exploit the antiinflammatory effects of Fc gammaR ligation to induce the production of IL-10, which renders macrophages refractory to the activating effects of IFN-gamma.
引用
收藏
页码:1141 / 1147
页数:7
相关论文
共 50 条
  • [1] Role of IL-10 in the progression of kidney disease
    Inna Sinuani
    Ilia Beberashvili
    Zhan Averbukh
    Judith Sandbank
    World Journal of Transplantation, 2013, 3 (04) : 91 - 98
  • [2] Influence of IL-10 from different cellular sources on leishmaniasis disease progression and immunity
    Schwarz, T.
    Remer, K. A.
    Siewe, L.
    Mueller, W.
    Roers, A.
    Moll, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 179 - 179
  • [3] The role of IL-10 in kidney disease
    Wei, Wei
    Zhao, Yibo
    Zhang, Yan
    Jin, Heng
    Shou, Songtao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [4] The role of paracrine IL-6 and IL-10 in neuroblastoma progression
    Song, Liping
    Ara, Tasnim
    Salo, Jill
    Deng, Zhong-bin
    Asgharzadeh, Shahab
    Ji, Lingyun
    Sposto, Richard
    DeClerck, Yves A.
    Seeger, Robert C.
    Metelitsa, Leonid S.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [5] Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy
    Murray, HW
    Lu, CM
    Mauze, S
    Freeman, S
    Moreira, AL
    Kaplan, G
    Coffman, RL
    INFECTION AND IMMUNITY, 2002, 70 (11) : 6284 - 6293
  • [6] Association between interleukin 10 (IL-10) polymorphisms and leishmaniasis progression: a systematic review and meta-analysis
    Renata Rocha da Silva
    Fernanda de Santana Fontes Vasconcelos
    Débora dos Santos Tavares
    Priscila Lima dos Santos
    Scientific Reports, 12
  • [7] Association between interleukin 10 (IL-10) polymorphisms and leishmaniasis progression: a systematic review and meta-analysis
    da Silva, Renata Rocha
    Fontes Vasconcelos, Fernanda de Santana
    Tavares, Debora dos Santos
    dos Santos, Priscila Lima
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] Is the IL-10 −819 Polymorphism Associated with Visceral Leishmaniasis?
    Mehrdad Hajilooi
    Kosro Sardarian
    Maryam Dadmanesh
    Mohamad Matini
    Pegah Lotfi
    Ahad Bazmani
    Mohammad Amin Tabatabaiefar
    Mohammad Kazemi Arababadi
    Mohammad Momeni
    Inflammation, 2013, 36 : 1513 - 1518
  • [9] IL-10 modulating immunosuppression in disseminated cutaneous leishmaniasis
    Sousa dos Santos, L. P.
    de Queiroz Sousa, A.
    Torres Sindeaux Filho, P. D.
    Magno Cavalcante, D. I.
    Miranda Sa, K.
    de Lima Pompeu, M. M.
    VIRCHOWS ARCHIV, 2019, 475 : S365 - S365
  • [10] Genetic variation in IL-10 influences the progression of Parkinson's disease
    Huang, Y
    Rowe, D
    Cook, NL
    Halliday, GM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S355 - S355